Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the outcome of treatment for bacteremic MRSA infection with vancomycin alone, vancomycin plus gentamicin, vancomycin plus rifampin, and vancomycin plus gentamicin and rifampin.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Michael E. DeBakey VA Medical Center; VA Medical Center, Houston
• Collaborator: Baylor College of Medicine
• Treatments: Gentamicins; Methicillin; Rifampin; Vancomycin

Criteria

Inclusion Criteria:

• Patients with MRSA in a blood culture processed as standard of care at the VAMC

• Patients or next of kin willing to sign consent to be randomized by social security number to one of the treatments.

Exclusion Criteria:

• none